Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
This intro clarifies what 2024 Total Market Return implies for portfolios, taxes, and long-term planning in plain language.
28,280 articlesModerna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
The question 'Is corp. stock seriously undervalued?' isn’t easy to answer for FMC. A mix of debt, patent risk, and a ...
A famous TV moment becomes a blueprint for managing money, trust, and outcomes. Learn actionable steps to protect you...
Medical scares can shake your finances. This guide shows how to rebound with a solid plan: emergency funds, smart ins...
Zillow’s antitrust filing targets Chicago MLS and a major brokerage network, prompting a heated LinkedIn discussion a...
A CNBC analyst argues that a pivotal policy move on April 9 reshaped the S&P 500’s trajectory, turning volatility int...
A new examination of long-run market data shows missing just a handful of the top trading days can erase the bulk of ...
As summer approaches, investors debate whether the market is primed for a rally or headed for a slump. This guide bre...
Anthropic has filed a confidential S-1, triggering a summer wave of AI IPO chatter. Private-market dynamics, competit...
SpaceX is lining up what could be the largest IPO in U.S. history, targeting about $75 billion by selling hundreds of...
A fresh study shows a sizable share of U.S. investors retreat from markets during downturns, costing them years of po...
Walmart's cautious forecast unsettles investors, pulling the S&P 500 lower as traders reassess retail margins and cos...